Basic Information
| LncRNA/CircRNA Name | HOXC13-AS |
| Synonyms | ENSG00000249641 |
| Region | GRCh38_12:53935328-53939643 |
| Ensemble | ENSG00000249641 |
| Refseq | NR_047507 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | qPCR, Luciferase reporter assay, Western blot, RIP |
| Sample | Glioma tissues,cell lines (LN229, U251, U87,U118) |
| Expression Pattern | up-regulated |
| Function Description | In the current study, a novel lncRNA which hasn?? been identified in glioma, HOXC13-AS (ENSG00000249641), was reported to be upregulated in both glioma cells and tissues. |
| Pubmed ID | 31564901 |
| Year | 2019 |
| Title | HOXC13-AS-miR-122-5p-SATB1-C-Myc feedback loop promotes migration, invasion and EMT process in glioma. |
External Links
| Links for HOXC13-AS | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |